Pil Italica Lifestyle Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 11, 2025, 8:51 pm

Quick Insight

Pil Italica Lifestyle Ltd, operating in the plastics industry, currently trades at ₹14.6 with a market capitalization of ₹340 Cr. The company's P/E ratio stands at 64.5, indicating a premium investors are willing to pay for its earnings. Despite a ROE of 6.18% and ROCE of 8.90%, both below industry averages, Pil Italica maintains a healthy OPM of 9.62%. With a low FII ownership at 0.00% and DIIs holding just 0.65%, the company relies heavily on promoter and public ownership. However, its high P/BV ratio of 4.30x suggests overvaluation, while a comfortable ICR of 6.52x indicates a strong ability to cover interest payments. Pil Italica's financial health, though stable, warrants caution for investors due to its inflated valuation relative to book value.

Competitors of Pil Italica Lifestyle Ltd

All Competitor Stocks of Pil Italica Lifestyle Ltd

Quarterly Result

Last Updated: August 1, 2025, 3:20 pm

Below is a detailed analysis of the quarterly data for Pil Italica Lifestyle Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 24.04 Cr.. The value appears to be declining and may need further review. It has decreased from 26.92 Cr. (Mar 2025) to 24.04 Cr., marking a decrease of 2.88 Cr..
• For Expenses, as of Jun 2025, the value is 21.30 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 24.33 Cr. (Mar 2025) to 21.30 Cr., marking a decrease of 3.03 Cr..
• For Operating Profit, as of Jun 2025, the value is 2.74 Cr.. The value appears strong and on an upward trend. It has increased from 2.59 Cr. (Mar 2025) to 2.74 Cr., marking an increase of 0.15 Cr..
• For OPM %, as of Jun 2025, the value is 11.40%. The value appears strong and on an upward trend. It has increased from 9.62% (Mar 2025) to 11.40%, marking an increase of 1.78%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.08 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.08 Cr..
• For Interest, as of Jun 2025, the value is 0.23 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.35 Cr. (Mar 2025) to 0.23 Cr., marking a decrease of 0.12 Cr..
• For Depreciation, as of Jun 2025, the value is 0.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.43 Cr. (Mar 2025) to 0.44 Cr., marking an increase of 0.01 Cr..
• For Profit before tax, as of Jun 2025, the value is 2.07 Cr.. The value appears strong and on an upward trend. It has increased from 1.89 Cr. (Mar 2025) to 2.07 Cr., marking an increase of 0.18 Cr..
• For Tax %, as of Jun 2025, the value is 25.12%. The value appears to be improving (decreasing) as expected. It has decreased from 42.86% (Mar 2025) to 25.12%, marking a decrease of 17.74%.
• For Net Profit, as of Jun 2025, the value is 1.55 Cr.. The value appears strong and on an upward trend. It has increased from 1.07 Cr. (Mar 2025) to 1.55 Cr., marking an increase of 0.48 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.07. The value appears strong and on an upward trend. It has increased from 0.05 (Mar 2025) to 0.07, marking an increase of 0.02.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:30 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: August 11, 2025, 2:31 pm

Below is a detailed analysis of the balance sheet data for Pil Italica Lifestyle Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 24.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 24.00 Cr..
• For Reserves, as of Mar 2025, the value is 56.00 Cr.. The value appears strong and on an upward trend. It has increased from 51.00 Cr. (Mar 2024) to 56.00 Cr., marking an increase of 5.00 Cr..
• For Borrowings, as of Mar 2025, the value is 9.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 16.00 Cr. (Mar 2024) to 9.00 Cr., marking a decrease of 7.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.00 Cr. (Mar 2024) to 8.00 Cr., marking an increase of 1.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 97.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 97.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 44.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Mar 2024) to 44.00 Cr., marking an increase of 13.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
• For Other Assets, as of Mar 2025, the value is 51.00 Cr.. The value appears to be declining and may need further review. It has decreased from 64.00 Cr. (Mar 2024) to 51.00 Cr., marking a decrease of 13.00 Cr..
• For Total Assets, as of Mar 2025, the value is 97.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 97.00 Cr..

Notably, the Reserves (56.00 Cr.) exceed the Borrowings (9.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Pil Italica Lifestyle Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 5. It has increased from 0.20 (Mar 24) to 0.22, marking an increase of 0.02.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 5. It has increased from 0.20 (Mar 24) to 0.22, marking an increase of 0.02.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.28. This value is below the healthy minimum of 3. It has increased from 0.23 (Mar 24) to 0.28, marking an increase of 0.05.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 3.38. It has increased from 3.16 (Mar 24) to 3.38, marking an increase of 0.22.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 3.38. It has increased from 3.16 (Mar 24) to 3.38, marking an increase of 0.22.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 4.26. It has increased from 4.14 (Mar 24) to 4.26, marking an increase of 0.12.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 0.42. This value is below the healthy minimum of 2. It has increased from 0.34 (Mar 24) to 0.42, marking an increase of 0.08.
• For PBIT / Share (Rs.), as of Mar 25, the value is 0.36. This value is within the healthy range. It has increased from 0.30 (Mar 24) to 0.36, marking an increase of 0.06.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.29. This value is within the healthy range. It has increased from 0.26 (Mar 24) to 0.29, marking an increase of 0.03.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 2. It has increased from 0.19 (Mar 24) to 0.22, marking an increase of 0.03.
• For PBDIT Margin (%), as of Mar 25, the value is 10.03. This value is within the healthy range. It has increased from 8.35 (Mar 24) to 10.03, marking an increase of 1.68.
• For PBIT Margin (%), as of Mar 25, the value is 8.53. This value is below the healthy minimum of 10. It has increased from 7.40 (Mar 24) to 8.53, marking an increase of 1.13.
• For PBT Margin (%), as of Mar 25, the value is 6.99. This value is below the healthy minimum of 10. It has increased from 6.37 (Mar 24) to 6.99, marking an increase of 0.62.
• For Net Profit Margin (%), as of Mar 25, the value is 5.23. This value is within the healthy range. It has increased from 4.75 (Mar 24) to 5.23, marking an increase of 0.48.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.60. This value is below the healthy minimum of 15. It has increased from 6.22 (Mar 24) to 6.60, marking an increase of 0.38.
• For Return on Capital Employeed (%), as of Mar 25, the value is 10.32. This value is within the healthy range. It has increased from 9.37 (Mar 24) to 10.32, marking an increase of 0.95.
• For Return On Assets (%), as of Mar 25, the value is 5.39. This value is within the healthy range. It has increased from 4.75 (Mar 24) to 5.39, marking an increase of 0.64.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.11. This value is within the healthy range. It has decreased from 0.21 (Mar 24) to 0.11, marking a decrease of 0.10.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.03. It has decreased from 1.06 (Mar 24) to 1.03, marking a decrease of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 3.51. This value exceeds the healthy maximum of 3. It has increased from 3.12 (Mar 24) to 3.51, marking an increase of 0.39.
• For Quick Ratio (X), as of Mar 25, the value is 2.34. This value exceeds the healthy maximum of 2. It has increased from 2.24 (Mar 24) to 2.34, marking an increase of 0.10.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.10. This value is below the healthy minimum of 4. It has decreased from 3.13 (Mar 24) to 3.10, marking a decrease of 0.03.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.52. This value is within the healthy range. It has decreased from 8.08 (Mar 24) to 6.52, marking a decrease of 1.56.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.40. This value is within the healthy range. It has decreased from 5.59 (Mar 24) to 4.40, marking a decrease of 1.19.
• For Enterprise Value (Cr.), as of Mar 25, the value is 348.16. It has increased from 290.08 (Mar 24) to 348.16, marking an increase of 58.08.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.48. This value exceeds the healthy maximum of 3. It has increased from 2.98 (Mar 24) to 3.48, marking an increase of 0.50.
• For EV / EBITDA (X), as of Mar 25, the value is 34.65. This value exceeds the healthy maximum of 15. It has decreased from 35.71 (Mar 24) to 34.65, marking a decrease of 1.06.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.41. This value exceeds the healthy maximum of 3. It has increased from 2.84 (Mar 24) to 3.41, marking an increase of 0.57.
• For Price / BV (X), as of Mar 25, the value is 4.30. This value exceeds the healthy maximum of 3. It has increased from 3.73 (Mar 24) to 4.30, marking an increase of 0.57.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.41. This value exceeds the healthy maximum of 3. It has increased from 2.84 (Mar 24) to 3.41, marking an increase of 0.57.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness